Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DUBLIN, Ireland, July 17, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), today announced it will report its second quarter 2018 financial results on Tuesday, August 7, 2018,...
-
DUBIN, Ireland, May 31, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), “Avadel” or the “Company,” today announced that management will present at two upcoming investor...
-
Data demonstrates extended first uninterrupted sleep period in elderly patients Key opinion leaders to present “NOCTIVA™: Addressing a Nighttime Condition with Daytime Consequences” DUBLIN, Ireland,...
-
NOCTIVA™ launch underway across the U.S. FT 218 granted Orphan Drug Designation Generated revenue of $33.3 million DUBLIN, Ireland, May 02, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc...
-
DUBLIN, Ireland, May 01, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL) today announced the launch of NOCTIVA™ (desmopressin acetate), an emulsified microdose Nasal Spray. NOCTIVA...
-
DUBLIN, Ireland, April 30, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), “Avadel” or “the Company,” today announced that Greg Divis, Chief Operating Officer, and Mike Kanan,...
-
DUBLIN, Ireland, April 24, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), today announced it will report its first quarter 2018 financial results on Wednesday, May 2, 2018,...
-
DUBLIN, Ireland, April 03, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), “Avadel” or the “Company,” today announced that new data from NOCTIVA’s pivotal Phase III clinical...
-
DUBLIN, Ireland, March 22, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), “Avadel” or the “Company,” today announced the promotion of Gregory J. Divis to Executive Vice President...
-
DUBLIN, Ireland, March 09, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq AVDL), “Avadel” or “the Company,” today announced that management will present at two upcoming investor...